Brooks Laboratories Limited (BROOKS) Stock Price & Analysis

2 Followers

BROOKS Stock Chart & Stats

₹65.91₹1.23(1.90%)

At close: Nov 04 3:30 PM GMT+5:30

Day’s Range: INR 65.23 - INR 70.00
52-Week Range: INR 36.50 - INR 111.55
Previous Close: INR 64.68
Volume: N/A
Average Volume (3M): 19.04K
Market Cap: INR 1.91B
Enterprise Value: INR 1.11B
Total Cash (Recent Filing): INR 66.73M
Total Debt (Recent Filing): INR 0
Price to Earnings (P/E): 14.6
Beta: 1.77
Next Earnings: Nov 07, 2026 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Bulls Say, Bears Say

Bulls Say

Low Leverage

Very low leverage gives Brooks financial flexibility to withstand operating volatility, fund selected investments, and manage obligations without heavy interest pressure. The sizable equity base also provides a stronger cushion if profitability weakens again over the next several quarters.

Profitability Turnaround

The return to strong profitability and positive returns on equity indicates a meaningful improvement in earnings power compared with the prior loss-making period. If retained, this recovery can strengthen internal funding, support reinvestment, and improve the company’s competitive resilience.

Cash Flow Recovery

The move back to positive operating and free cash flow is an important foundation for business durability because it reduces reliance on external funding. Although conversion remains imperfect, the recovery improves Brooks’ ability to support operations and capital needs from internally generated cash.

Bears Say

Revenue Contraction

A sharp decline in revenue weakens the durability of the recent earnings recovery and may reduce operating leverage across the business. Sustained top-line pressure could limit scale benefits, constrain reinvestment, and make future profitability more dependent on cost control than demand growth.

Weak Cash Conversion

Cash generation is not yet keeping pace with reported earnings, which reduces confidence in the quality and repeatability of the profit rebound. Persistently weak conversion could constrain internally funded growth and make the business more exposed to working-capital or operating fluctuations.

Profitability Volatility

The history of substantial margin swings shows that recent profitability has not yet demonstrated consistent durability. Continued volatility could make earnings harder to forecast, weaken investor confidence in operating performance, and increase the risk that strong FY2026 margins normalize downward.

Brooks Laboratories Limited News

Brooks Laboratories Denies Role in Share Price Surge, Cites Full Compliance

Brooks Laboratories Limited ( ($IN:BROOKS) ) has provided an announcement. Brooks Laboratories Limited has clarified that it has fully complied with all material disclosure requirements under Indian securities regulations, asserting

3w ago

Brooks Laboratories Announces Strategic Merger of Joint Venture

Brooks Laboratories Limited ( ($IN:BROOKS) ) has shared an announcement. Brooks Laboratories Limited has announced a merger by absorption involving its joint venture, Brooks Steriscience Limited, and several other entities.

1y ago

BROOKS FAQ

What was Brooks Laboratories Limited’s price range in the past 12 months?

Brooks Laboratories Limited lowest stock price was ₹36.50 and its highest was ₹111.55 in the past 12 months.

What is Brooks Laboratories Limited’s market cap?

Brooks Laboratories Limited’s market cap is ₹1.91B.

When is Brooks Laboratories Limited’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Brooks Laboratories Limited’s earnings last quarter?

Brooks Laboratories Limited released its earnings results on Aug 13, 2026. The company reported -₹0.607 earnings per share for the quarter.

Is Brooks Laboratories Limited overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Brooks Laboratories Limited pay dividends?

Brooks Laboratories Limited does not currently pay dividends.

What is Brooks Laboratories Limited’s EPS estimate?

Brooks Laboratories Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Brooks Laboratories Limited have?

Brooks Laboratories Limited has 29,457,249 shares outstanding.

What happened to Brooks Laboratories Limited’s price movement after its last earnings report?

Brooks Laboratories Limited reported an EPS of -₹0.607 in its last earnings report. Following the earnings report the stock price went up 5%.

Which hedge fund is a major shareholder of Brooks Laboratories Limited?

Currently, no hedge funds are holding shares in IN:BROOKS

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description